Steve Braunstein
Overview
Explore the profile of Steve Braunstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
2823
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Willcox J, Gregg A, Braunstein S, Mattes M, Gunther J, Abrams M
Pract Radiat Oncol
. 2024 Dec;
PMID: 39733966
Purpose: Many medical students in the US lack formal exposure to radiation oncology (RO). In contrast to multi-week electives, microclerkships, defined here as brief (<1 week) observerships, could provide exposure...
2.
Jiao C, Lao Y, Zhang W, Braunstein S, Salans M, Villanueva-Meyer J, et al.
Phys Med Biol
. 2024 Jul;
69(15).
PMID: 39019073
We aim to develop a Multi-modal Fusion and Feature Enhancement U-Net (MFFE U-Net) coupling with stem cell niche proximity estimation to improve voxel-wise Glioblastoma (GBM) recurrence prediction.57 patients with pre-...
3.
Vasudevan H, Braunstein S
World Neurosurg
. 2024 Jul;
188:252.
PMID: 39010342
No abstract available.
4.
Rudie J, Saluja R, Weiss D, Nedelec P, Calabrese E, Colby J, et al.
Radiol Artif Intell
. 2024 Feb;
6(2):e230126.
PMID: 38381038
5.
Ramesh P, Ruan D, Liu S, Seo Y, Braunstein S, Sheng K
Med Phys
. 2024 Feb;
51(3):2320-2333.
PMID: 38345134
Background: Variable relative biological effectiveness (RBE) models in treatment planning have been proposed to optimize the therapeutic ratio of proton therapy. It has been reported that proton RBE decreases with...
6.
Salans M, Ni L, Morin O, Ziemer B, Capaldi D, Raleigh D, et al.
J Neurooncol
. 2024 Feb;
166(3):535-546.
PMID: 38316705
Background: Adverse radiation effect (ARE) following stereotactic radiosurgery (SRS) for brain metastases is challenging to distinguish from tumor progression. This study characterizes the clinical implications of radiologic uncertainty (RU). Methods:...
7.
Osorio R, Haddad A, Hart D, Goldrich N, Badani A, Kabir A, et al.
J Neurosurg
. 2023 Oct;
140(3):712-723.
PMID: 37877974
Objective: Socioeconomic status (SES) is known to affect presentations and outcomes in pituitary neuroendocrine tumor resections, but there is a paucity of literature examining its impact specifically on patients with...
8.
Vargas E, Shabani S, Mummaneni P, Park C, Ben-Natan A, Rivera J, et al.
J Neurosurg Spine
. 2023 May;
39(2):287-294.
PMID: 37148234
Objective: In the absence of spinal cord compression, it is unclear if surgery is more effective than radiation treatment for improving functional outcomes in metastatic spinal tumor patients with potentially...
9.
Rusthoven C, Staley A, Gao D, Yomo S, Bernhardt D, Wandrey N, et al.
J Natl Cancer Inst
. 2023 May;
115(8):926-936.
PMID: 37142267
Introduction: Historical reservations regarding stereotactic radiosurgery (SRS) for small-cell lung cancer (SCLC) brain metastases include concerns for short-interval and diffuse central nervous system (CNS) progression, poor prognoses, and increased neurological...
10.
Raleigh D, Chen W, Choudhury A, Youngblood M, Polley M, Lucas C, et al.
Res Sq
. 2023 Mar;
PMID: 36993741
Background: Surgery is the mainstay of treatment for meningioma, the most common primary intracranial tumor, but improvements in meningioma risk stratification are needed and current indications for postoperative radiotherapy are...